Home
About Us
About Us
Our Team
News & Press
Why Ultra-Rare Diseases
Our Model
Therapy Tracker
Contact
Select Page
LGMDR5
Back to Therapy Pipeline
Submitting Organization:
The Dion Foundation
Treatment Modality:
Gene Therapy
Development Stage:
Preclinical Phase - Target Validation